Araştırma Makalesi

Does the measurement of the size of the first trimester subchorionic hematoma by 2D and 3D ultrasonographic techniques have any effect on adverse pregnancy outcomes?

Cilt: 4 Sayı: 3 1 Aralık 2019
PDF İndir
EN TR

Does the measurement of the size of the first trimester subchorionic hematoma by 2D and 3D ultrasonographic techniques have any effect on adverse pregnancy outcomes?

Abstract

Aim: We aimed to evaluate whether the measurement of subchorionic hematoma (SCH) size with 2D and 3D ultrasonography affects adverse pregnancy outcomes.

Methods: One hundred fifty-eight pregnant patients having SCH were enrolled in the study. The diagnosis of SCH was made by 2D and 3D ultra-sonographic methods in the first trimester, between 6th and 14th gestational weeks. Patients having SCH were determined with adverse pregnancy outcomes such as miscarriage, intrauterine fetal death (IUFD), and preterm labor (PL). Logistic regression analyses were applied for the relationship of miscarriage, IUFD, PL, and SCH.

Results: There were no statistically significant differences for body mass index, 2-D hematoma sizes, 3-D hematoma sizes, and pregnancy outcomes between the groups. Miscarriage/IUFD rate was 4.6%, PL rate was 6.9%, and the term delivery rate was 88.5% in the primiparas having SCH. Miscarriage/IUFD rate was 7%, PL rate was 3.5%, and the term delivery rate was 89.5% in the multiparas having SCH. No significant association was observed between 2D and 3D hematoma sizes and IUFD and PL. In the logistic regression model, SCH ≥ 500 cm3 was found to be a risk factor associated with PL, not regarding the measurement technique (OR:1.008, 95% CI: 1.002-1.012, p=0.006).

Conclusion: We determined that SCH size increases the risk of PL. We observed no effect of diagnosis and follow-up of SCH, by 2D and 3D ultrasonography techniques on adverse pregnancy outcomes such as miscarriage, IUFD, and PL.

Keywords

Destekleyen Kurum

Yok

Proje Numarası

approval date/number:05.04.2019/004

Teşekkür

Çalışmaya dahil olan tüm hastalarımıza teşekkür ederiz.

Kaynakça

  1. 1. Mallin M, Dawson M, Schroeder E, Hatch B, Jackson I, Ahern M, et al. Prospective outcomes of pregnant ED patients with documented fetal cardiac activity on ultrasound. Am J Emerg Med. 2012;30:472-5.
  2. 2. Seki H, Kuromaki K, Takeda S, Kinoshita K. Persistent subchorionic hematoma with clinical symptoms until delivery. Int J Gynecol Obstet. 1998;63:123–8.
  3. 3. Maso G, D’Ottavio G, De Seta F, Sartore A, Piccoli M, Mandruzzato G. First-trimester intrauterine hematoma and outcome of pregnancy. Obstet Gynecol. 2005;105:339–44.
  4. 4. Weiss JL, Malone FD, Vidaver J, Ball RH, Nyberg DA, Comstock CH, et al. Threatened miscarriage: A risk factor for poor pregnancy outcome, a population-based screening study. Am J Obstet Gynecol. 2004;190:745–50.
  5. 5. Tuuli MG, Norman SM, Odibo AO, Macones GA, Cahill AG. Perinatal Outcomes in Women With Subchorionic Hematoma.Obstet Gynecol. 2011;117:1205-12.
  6. 6. Brown DL, DiSalvo DN, Frates MC, Davidson KM, Genest DR: Placental surface cysts detected on sonography: Histologic and clinical correlation. J Ultrasound Med. 2002;21:641–6.
  7. 7. Riccabona M, Nelson TR, Pretorius DH, Davidson TE. In vivo three-dimensional sonographic measurements of organ volume: validation in the urinary bladder. J Ultrasound Med. 1996; 15:627-632.
  8. 8. Keys A, Fidanza F, Karvonen MJ, Kimura N, Taylor HL. Indices of relative weight and obesity. J Chron Dis. 1972;25:329–43.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Cerrahi

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

1 Aralık 2019

Gönderilme Tarihi

3 Temmuz 2019

Kabul Tarihi

16 Ağustos 2019

Yayımlandığı Sayı

Yıl 2019 Cilt: 4 Sayı: 3

Kaynak Göster

Vancouver
1.Sibel Özler, Başak Gümüş Güler. Does the measurement of the size of the first trimester subchorionic hematoma by 2D and 3D ultrasonographic techniques have any effect on adverse pregnancy outcomes? Arch Clin Exp Med. 01 Aralık 2019;4(3):122-6. doi:10.25000/acem.586513